Open house Umeclidiniumbromid discount agreements

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Mar 05, 2027 · 188 days left·Open·Supplies·Framework

Inscrivez-vous pour sauvegarder Open documents

Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Umeclidiniumbromid, ATC R03BB07

60/100

Score d'opportunité

PromisingLow complexity

SuppliesFrameworkOpen

Pourquoi ce score ?

Opportunité

60 / 100

Complexité

20 / 100

Facteurs de risque

Agreements are non-exclusive and can be terminated automatically if a competitive discount contract is concluded for th...

No estimated value provided; potential revenue is uncertain.

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Aperçu

Strong opportunity

Faits clés

Framework procurement
Supplies contract
1 lot
Duration until Apr 2027
Provision of Umeclidiniumbromid (ATC R03BB07) pharmaceutical products
Conclusion of a non-exclusive discount agreement under §130a Abs. 8 SGB V

Afficher le résumé complet

This is an Open-House model (not a public procurement procedure) by AOK Bayern to conclude non-exclusive discount agreements for the active substance Umeclidiniumbromid (ATC R03BB07) with all interested pharmaceutical companies that meet the eligibility criteria. Contracts run from 01.05.2025 to 30.04.2027. Joining is possible until 05.03.2027. No competitive selection; any eligible company can join. Estimated value is not provided. Performance is in Bavaria, Germany.

Risques

Agreements are non-exclusive and can be terminated automatically if a competitive discount contract is concluded for th...

No estimated value provided; potential revenue is uncertain.

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Eligibility

Only pharmaceutical companies are eligible to participate

Administrative

Submission of a signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit)
Submission of a signed contract agreement including annex 'Festlegung der vertragsgegenständlichen Arzneimittel'

Acheteur

Nom

AOK Bayern - Die Gesundheitskasse

Localisation

München, DEU

[email protected]

Site web

www.aok.de

Profil acheteur

Ouvrir le profil

Identifiant

DE811695320

Activité

Health

Lots (1)

LOT-0001

Open house Umeclidiniumbromid discount agreements

Non-exclusive discount agreements for Umeclidiniumbromid (ATC R03BB07). All pharmaceutical companies that meet the eligibility criteria can join. Contracts are identical and non-negotiable. Duration: 01.05.2025 - 30.04.2027. Automatic termination if a national or regional discount contract is concluded via a competitive procedure.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE212, Germany

Durée

Apr 2025 - Apr 2027

Catégorie

Pharmaceutical products

Date limite

Deadline Mar 05, 2027

Détails de la procédure

Date de publication: 18 Mar 2025
Langues: German

Métadonnées de référence

Base juridique: 32014L0024

Identifiants de référence

ID de l'appel d'offres: 178944-2025

Documents (2)

Document de consultation 1 Portail de soumission 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3